News
EQS-Adhoc: GN Store Nord A/S: GN announces appointment of new CEO in GN Audio
EQS-Adhoc: GN Store Nord A/S: GN announces appointment of new CEO in GN Audio
EQS-News: Invitation to MorphoSys’ Third Quarter and First Nine Months 2022 Results Conference Call on November 17, 2022
EQS-News: Invitation to MorphoSys’ Third Quarter and First Nine Months 2022 Results Conference Call on November 17, 2022
U.S. News and World Report names Humana 2023 Best Overall Medicare Advantage Plan Company
Humana recently received recognition as U.S. News & World Report’s Best Insurance Company for Medicare Advantage in three categories for 2023.
This press release features multimedia. View the full
EQS-News: RHÖN-KLINIKUM AG closes first nine months of 2022 with revenue surplus
EQS-News: RHÖN-KLINIKUM AG closes first nine months of 2022 with revenue surplus
EQS-News: Evotec SE reports results for the first nine months 2022 and provides corporate update
EQS-News: Evotec SE reports results for the first nine months 2022 and provides corporate update
EQS-News: Biotest AG: Biotest reports sales of Euro 361 million in the first nine months of 2022
EQS-News: Biotest AG: Biotest reports sales of Euro 361 million in the first nine months of 2022
EQS-News: MorphoSys to Share New Data on Pelabresib and Monjuvi® (tafasitamab-cxix) in 14 Presentations at the American Society of Hematology Annual Meeting
EQS-News: MorphoSys to Share New Data on Pelabresib and Monjuvi® (tafasitamab-cxix) in 14 Presentations at the American Society of Hematology Annual Meeting
EQS-News: Evotec SE to announce results for the first nine months 2022 on 09 November 2022
EQS-News: Evotec SE to announce results for the first nine months 2022 on 09 November 2022
EQS-News: Evotec completes acquisition of Central Glass Germany
EQS-News: Evotec completes acquisition of Central Glass Germany
AEVIS VICTORIA SA – AEVS.SW – Nine-month revenues up 35.5% to CHF 831.0 million
AEVIS VICTORIA SA – AEVS.SW – Nine-month revenues up 35.5% to CHF 831.0 million
EQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2022
EQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2022
EQS-Adhoc: GN Store Nord A/S: GN Store Nord’s Audio division revises financial guidance for 2022
EQS-Adhoc: GN Store Nord A/S: GN Store Nord’s Audio division revises financial guidance for 2022
EQS-News: Evotec presents paradigm shift in biologics at Capital Markets Day
EQS-News: Evotec presents paradigm shift in biologics at Capital Markets Day
Dexcom Partners With Warriors and Nonprofits to Artfully Advocate for Access to Diabetes Care
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes will come together with members of the diabetes community during National Diabetes
CORRECTING and REPLACING Acadia Healthcare Reports Third Quarter 2022 Results
There was an inadvertent error on the supplementary table titled “Reconciliation of Net Income Attributable to Acadia Healthcare Company, Inc. to Adjusted Income Attributable to Acadia Healthcare
EQS-Adhoc: Challenging macroeconomic environment impact Fresenius Medical Care and Fresenius Group earnings in FY/22; Fresenius SE & Co. KGaA Group guidance revised
EQS-Adhoc: Challenging macroeconomic environment impact Fresenius Medical Care and Fresenius Group earnings in FY/22; Fresenius SE & Co. KGaA Group guidance revised
EQS-News: Fresenius Medical Care AG & Co. KGaA revises financial outlook for full year 2022
EQS-News: Fresenius Medical Care AG & Co. KGaA revises financial outlook for full year 2022
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA extends net income target range for financial year 2022
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA extends net income target range for financial year 2022
AEVIS VICTORIA SA – AEVS.SW – Visana enters into the share capital of Hôpital du Jura Bernois, a subsidiary of Swiss Medical Network
AEVIS VICTORIA SA – AEVS.SW – Visana enters into the share capital of Hôpital du Jura Bernois, a subsidiary of Swiss Medical Network
EQS-News: Evotec, CDP Venture Capital and Angelini Ventures launch translational partnership 'Extend' with leading Italian academic Institutions
EQS-News: Evotec, CDP Venture Capital and Angelini Ventures launch translational partnership 'Extend' with leading Italian academic Institutions
EQS-News: MorphoSys Presents Preliminary Results from Phase 1/2 Study of Tulmimetostat (CPI-0209) Supporting Its Potential Application in a Broad Array of Advanced Tumors
EQS-News: MorphoSys Presents Preliminary Results from Phase 1/2 Study of Tulmimetostat (CPI-0209) Supporting Its Potential Application in a Broad Array of Advanced Tumors
EQS-News: GSK, MorphoSys’ Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis
EQS-News: GSK, MorphoSys’ Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis
EQS-News: Drägerwerk AG & Co. KGaA: Dräger expects faster sales recognition in the fourth quarter of 2022
EQS-News: Drägerwerk AG & Co. KGaA: Dräger expects faster sales recognition in the fourth quarter of 2022
EQS-News: Evotec enters partnership with Hannover Medical School to create molecular patient database in autoimmune diseases
EQS-News: Evotec enters partnership with Hannover Medical School to create molecular patient database in autoimmune diseases
Dexcom, Adam Schefter Announce Dexcom U, the First NIL Program for College Athletes With Diabetes
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the launch of Dexcom U, the first-ever NIL (name, image